Skip to main content
Learn About Treatment
Types of Addiction Treatment
See Addiction Treatment Best Practices
Determine treatment needs
Take the Addiction Treatment Needs Assessment
Find and pay for treatment
Find High-quality Addiction Treatment
Identify the Right Provider
Ask Providers These Questions
Where your money goes
Drug Types and Effects
Public Health Crisis
Science of Addiction
All About Opioids
Addiction & Mental Health
All About Naloxone
Infections and Drug Use
Safe Disposal of Prescription Medication
Medications for Addiction Treatment (MAT)
National Principles of Care
First 90 Days
Substance Use Disorder Treatment Task Force
National Principles of Care
Learn about stigma
See how stigma affects the opioid epidemic
Learn how you can help
See our plan to combat stigma
Get our Strategy to End Stigma
Pledge to reduce stigma
Managing Patients with OUD
Federal & State Priorities
Our position on the issues
Workplace Cost Calculator
Fundraise for Shatterproof
Join the Shatterproof Challenge
Create Your Own Fundraiser
Advocate for Change
Federal & State Policy Priorities
Position Papers & Policy Information
Take Action Now
Share your Story
Share your recovery story
Create a memorial
Join the Shatterproof Circle
Become an Ambassador
Shatterproof’s leadership team consists of doctors, executives, addiction specialists, and people affected by substance use disorders. They are committed to reversing the course of the addiction crisis in the United States.
Board of Directors
Managing Director and CIO, ICG
President and a member of the Board of Directors of The Suzanne Wright Foundation
Jonathan E. Fielding, M.D.
Co-Director, UCLA Center for Healthier Children, Families and Communities
President of Finkelstein & Co.
Gary Henson, CFA
President, Tortoise Investments
Former Cigna President of US Business Segments, Specialty Businesses, and Global Strategy
Founder and CEO
Chair, Real Estate Capital Markets Group, Goodwin Proctor LLP
co-CEO, Mitchells Stores
CEO, HEI Hotels & Resorts
Jennifer G. Velez
Managing Director, Sales and Marketing, McLaren Racing Ltd.
Board of Advisors
Donald Berwick, M.D., M.P.P.
Former Administrator, Centers for Medicare and Medicaid Services; Former President & CEO, Institute for Healthcare Improvement
Executive Vice President and Chief Financial Officer, City National Bank
Thomas J. Corcoran, Jr.
TCOR Hotel Partners
Robert L. DuPont, M.D.
First Director, National Institute of Drug Abuse; Former White House Drug Chief
Senior-Level Health Care Executive
The Honorable Patrick Kennedy
Former Congressman; Co-Founder, One Mind for Research
Manager of Digital Engagement at the National Education Association
Executive Director of Media and Innovation for Mercy College
Mark G. Miller
Former Managing Director of Citigroup Global Markets and Blackrock Inc
Dr. Andrey Ostrovsky is the Chief Medical Officer and SVP of Behavioral Health at Solera Health
CEO of Women’s Intimate Apparel for USA and Great Britain and President of the Company’s Delta Galil USA segment
Co-head of Crow Holdings Capital Investment Partners
CEO, AllMed Heathcare Management
CEO of The Public Good Projects (PGP)
SVP, Wealth Management, Merrill Lynch
Dr. Leana Wen
Emergency Physician, Public Health Leader, Advocate for Patient-Centered Healthcare Reform
Owner of Bridge Strategic Communications
Amelia Arria, Ph.D.
Associate Professor, Department of Behavioral and Community Health; Director, Center on Youth Adult Health and Development, University of Maryland School of Public Health
Alisa Bahl, Ph.D.
SVP, Clinical Alliances, Magellan Health
SVP and Chief Pharmacy Officer, OptumRX
Richard Catalano, Ph.D.
Professor & Director, Social Development Research Group, University of Washington
Larry Gentilello, M.D.
Professor of Surgery, Adjunct Professor of Management, Policy and Community Health, University of Texas; Former President, Society for Prevention Research
Martin H. Rosenzweig, MD
Senior Behavioral Medical Director with Optum
David Hawkins, Ph.D.
Professor & Founding Director, Social Development Research Group, University of Washington
Thomas McLellan, Ph.D.
Founder, Treatment Research Institute
Douglas Nemecek, M.D., M.B.A.
Chief Medical Officer for Behavioral Health, Cigna
Lipi Roy, MD, MPH, FASAM
Internal Medicine Physician, MSNBC and NBC News Medical Contributor
Opioid Overdose Advisory Board
Executive Director, Kentucky Office of Drug Control Policy
Andrew Kolodny, M.D.
Co-Director of The Opioid Policy Research Collaborative at the Heller School for Social Policy and Management
John L. Eadie
Director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University